The illusion of safety: A report to the FDA on AI healthcare product approvals.
PMID : 40471897 ·
R, a, w, a, n, , A, b, u, l, i, b, d, e, h, ;, , L, e, o, , A, n, t, h, o, n, y, , C, e, l, i, ;, , E, r, v, i, n, , S, e, j, d, i, ć
Publicité
Résumé
Artificial intelligence is rapidly transforming healthcare, offering promising advancements in diagnosis, treatment, and patient outcomes. However, concerns regarding the regulatory oversight of artificial intelligence driven medical technologies have emerged, particularly with the U.S. Food and Drug Administration's current approval processes. This paper critically examines the U.S. Food and Drug Administration's regulatory framework for artificial intelligence powered healthcare products, high
Publicité
Source officielle
Voir sur PubMed →Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.